IRMD
IRADIMED CORP
NASDAQ · Healthcare · Medical - Devices · US
$88.18
+8.72%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$82.73
From 52W high−16.14%
Volume62204.00
Market cap$1.13B
P/E (TTM)46.7x
P/S (TTM)12.6x
Div yield1.44%
Key dataNov 4, 2026
Open
$82.73
From 52W high
−16.14%
Volume
62204.00
Market cap
$1.13B
ValuationView details →
P/E (Fwd)
36.8x
EV/EBITDA
33.4x
P/E (TTM)
46.7x
RSI (14)
54.9
MomentumView details →
1D Return
+8.72%
YTD Return
−10.04%
SummaryUpdated Sep 1, 2026
IRadimed Corporation (NYSE:IRMD) is a specialized medical device manufacturer founded in 1992 and headquartered in Winter Springs, Florida. The company went public in July 2014 and has established itself as a leading provider of magnetic resonance imaging (MRI) compatible medical devices. IRadimed operates in the niche but critical market of developing equipment that can safely function within the powerful magnetic fields of MRI machines, serving hospitals, acute care facilities, and outpatient imaging centers across the United States and internationally.
Similar companies
Latest newsMore news →
IRADIMED CORP reported third-quarter 2026 revenue of $24.2 million, up 14% year over year and 18% from the second quarter, with GAAP diluted EPS of $0.51 and non-GAAP diluted EPS of $0.55.5d agoIRADIMED CORP announced that it will release its third-quarter 2026 financial results before the market opens on October 30 and hold a conference call that day at 11:00 a.m. Eastern Time.12d agoiRadimed began general-release production of its new 3870 MRI IV pump system in the second quarter of 2026.96d ago